RxDoctor Payments Data

Lacey Eden

Family · Bluffdale, UTNPI 1386972875

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $37,034 of the $55,795 with a category attached, or 66.4%. GSK accounts for 96.7% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2022 at $21,976 and has fallen 79.1% since, to $4,604 in 2025. Among family clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$55,795in general payments, 2019–2025

Across 224 payments — averaging $249.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$54K
  • Supernus Pharmaceuticals, Inc.$430
  • Corium, LLC$275
  • Tris Pharma Inc$170
  • Merck$138
  • Ironshore Pharmaceuticals Inc.$132
  • plus $672 from 14 others

What the payments were for

  • Speaking & faculty fees$37,03466%
  • Travel & lodging$15,37728%
  • Food & beverage$3,3846%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$55,795 in reported general payments places this provider in the 95th percentile of 1,460 family providers in Utah.

See all family providers in Utah

Other family in Bluffdale

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →